1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,905 | 0,950 | 12:48 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.04. | Bloom Burton & Co. Inc.: Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | 198 | Newsfile | Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment... ► Artikel lesen | |
| 28.03. | Hamilton Thorne reports Q4 results | 1 | Seeking Alpha | ||
| 27.03. | Hamilton Thorne Ltd: Hamilton Thorne loses $607,022 (U.S.) in 2023 | 2 | Stockwatch | ||
| 27.03. | Hamilton Thorne GAAP EPS of $0.00, revenue of $18.4M | 2 | Seeking Alpha | ||
| 27.03. | Hamilton Thorne Ltd.: Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023 | 68 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services... ► Artikel lesen | |
| 21.03. | Hamilton Thorne Ltd: Hamilton Thorne to release 2023 results March 27 | 2 | Stockwatch | ||
| 21.03. | Hamilton Thorne Ltd.: Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024 | 3 | GlobeNewswire (USA) | ||
| 21.12.23 | Hamilton Thorne Ltd: Hamilton Thorne appoints Torchilin as president, CEO | 1 | Stockwatch | ||
| 21.12.23 | Hamilton Thorne appoints Ekaterina Torchilin as president and CEO | 1 | Seeking Alpha | ||
| 21.12.23 | Hamilton Thorne Ltd.: Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO | 388 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive... ► Artikel lesen | |
| 13.11.23 | Hamilton Thorne GAAP EPS of -C$0.01, revenue of C$15.66M | 1 | Seeking Alpha | ||
| 13.11.23 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023 | 166 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive... ► Artikel lesen | |
| 07.11.23 | Hamilton Thorne Ltd.: Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023 | 1 | GlobeNewswire (USA) | ||
| 07.11.23 | Hamilton Thorne's ownership structure sees balance, hints at future prospects | 1 | Investing.com | ||
| 10.10.23 | Hamilton Thorne Ltd.: Hamilton Thorne Announces the Acquisition of Gynetics Medical Products N.V. | 366 | Newsfile | Strengthens Hamilton Thorne footprint in consumables within the Assisted Reproductive Technology marketExpands expertise, manufacturing, and product offerings in consumables in the ever-growing European... ► Artikel lesen | |
| 06.09.23 | Hamilton Thorne Ltd.: Hamilton Thorne Graduating to Toronto Stock Exchange Main Board | 258 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted... ► Artikel lesen | |
| 17.08.23 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended June 30, 2023 | 246 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive... ► Artikel lesen | |
| 15.05.23 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31, 2023 | 272 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 73,82 | -0,77 % | Cosmo Pharmaceuticals N.V.: Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care | Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology... ► Artikel lesen | |
| INTUITIVE SURGICAL | 361,45 | +3,20 % | Quartalszahlen: China sei Dank: Intuitive Surgical übertrifft Erwartungen, Aktie steigt! | © Foto: Frank Molter - picture allianceDie Aktie des Herstellers von Medizinrobotern Intuitive Surgical ist nach guten Quartalszahlen gefragt und steigt.Erholung in China ließ lange auf sich warten... ► Artikel lesen | |
| TELADOC HEALTH | 12,390 | +0,02 % | Teladoc Health, Inc.: Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25 | ||
| UNITEDHEALTH | 458,80 | -1,00 % | Quartalszahlen: US-Krankenversicherer vor Mega-Comeback? UnitedHealth mit starken Zahlen! | © Foto: Igor Golovniov - picture alliance / ZUMAPRESS.comDie zuletzt schwachen Papiere von US-Krankenversicherern könnten vor einem Comeback stehen: Branchenprimus UnitedHealth hat am Dienstag starke... ► Artikel lesen | |
| SERNOVA | 0,299 | -3,04 % | Sernova gibt positives Update zur klinischen Entwicklung und zum Plattform-Portfolio | - Patientendaten aus Kohorte 2 bei Typ-1-Diabetes (T1D) zeigen erfolgreiches Anwachsen und Funktionsaufnahme sowie Langzeitüberleben menschlicher
Spenderinselzellen in der Cell Pouch... ► Artikel lesen | |
| SYNLAB | 10,500 | -0,76 % | EQS-DD: SYNLAB AG: Prof. Dr. David Ebsworth, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
19.04.2024 / 10:04... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| HCA HEALTHCARE | 279,60 | +0,22 % | Smart Money Is Betting Big In HCA Options | ||
| AMEDISYS | 84,00 | +0,60 % | Amedisys, Inc.: Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results | BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods... ► Artikel lesen | |
| LANTHEUS | 58,72 | +0,20 % | Lantheus Holdings, Inc.: Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time | ||
| ENVISTA | 18,800 | +1,08 % | Envista Holdings Corporation: Envista Announces CEO Appointment | BREA, Calif., April 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced today the appointment of Paul Keel as Chief Executive Officer and a member of the Board of Directors... ► Artikel lesen | |
| CAREDX | 7,694 | +1,40 % | CareDx, Inc. - 8-K, Current Report | ||
| GT BIOPHARMA | 4,070 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results | Remain in active dialogue with the FDA regarding IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemiaPhase 1 trial with GTB-3650 anticipated to start in 2H... ► Artikel lesen | |
| SYNEOS HEALTH | 40,000 | 0,00 % | Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com | The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering.
The biopharmaceutical clinical development landscape... ► Artikel lesen | |
| CARMAT | 3,830 | +1,06 % | CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024 | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen |
HAMILTON THORNE LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,910 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
